Skip to content

Evaluation of the effect of plant-based food on influenza virus infection: a randomized, placebo-controlled, double-blind, parallel group comparison study.

Evaluation of the effect of plant-based food on influenza virus infection: a randomized, placebo-controlled, double-blind, parallel group comparison study. - Evaluation of the effect of plant-based food on influenza virus infection: a randomized, placebo-controlled, double-blind, parallel group comparison study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038293
Enrollment
2000
Registered
2019-10-15
Start date
2019-10-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza virus

Interventions

Subjects have one test food once a day for 12 weeks. Subjects have one test food without effective ingredients once a day for 12 weeks.

Sponsors

Kagome Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Subjects aged 20 to 59 years old. 2)Subjects without continuous medical treatment. 3)Subjects aware of having cold symptoms at least once a year. 4)Subjects giving written informed consent.

Exclusion criteria

Exclusion criteria: 1) Subjects with severe liver disorders, kidney / cardiac diseases, organ disorders, diabetes, food allergies, digestive disorders, and other serious diseases (including anamnesis). 2) Subjects having food similar to test food more than three times a week. 3)smokers. 4)Subjects with asbestos exposure history (such as coal mine workers). 5)Subjects with severe hay fever. 6) Pregnant women and/or lactating women, and women planning to do so during study period. 7) Alcoholics. 8) Subjects regularly using medicines, foods or supplements for specified health use. 9) Subjects with allergic reaction to test food. 10) Subjects unable to take the test food as directed. 11) Subjects attending other tests. 12)Subjects suffering from influenza between September 1st, 2019 and the date of consent. 13)Subjects working as medical professionals.

Design outcomes

Primary

MeasureTime frame
Incidence of influenza. Fever (over 37.5) frequency. Fever period.

Secondary

MeasureTime frame
Symptoms (headache, pharyngeal pain, cough, abdominal pain)

Countries

Japan

Contacts

Public ContactNatsumi Oka

APO PLUS STATION CO., LTD. CRO Department Food Test Division

n2-oka@apoplus.co.jp03-6386-8809

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026